Ironwood Pharmaceuticals Statistics
Total Valuation
IRWD has a market cap or net worth of $117.59 million. The enterprise value is $628.51 million.
Important Dates
The next estimated earnings date is Thursday, May 8, 2025, before market open.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
IRWD has 161.81 million shares outstanding. The number of shares has increased by 2.99% in one year.
| Current Share Class | 161.81M |
| Shares Outstanding | 161.81M |
| Shares Change (YoY) | +2.99% |
| Shares Change (QoQ) | -0.49% |
| Owned by Insiders (%) | 1.96% |
| Owned by Institutions (%) | 74.16% |
| Float | 123.64M |
Valuation Ratios
The trailing PE ratio is 131.39 and the forward PE ratio is 4.45.
| PE Ratio | 131.39 |
| Forward PE | 4.45 |
| PS Ratio | 0.33 |
| Forward PS | 0.41 |
| PB Ratio | -0.39 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 1.14 |
| P/OCF Ratio | 1.14 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 6.43, with an EV/FCF ratio of 6.08.
| EV / Earnings | 714.21 |
| EV / Sales | 1.79 |
| EV / EBITDA | 6.43 |
| EV / EBIT | 6.57 |
| EV / FCF | 6.08 |
Financial Position
The company has a current ratio of 4.69
| Current Ratio | 4.69 |
| Quick Ratio | 4.39 |
| Debt / Equity | n/a |
| Debt / EBITDA | 5.89 |
| Debt / FCF | 5.80 |
| Interest Coverage | 2.88 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 14.56% |
| Return on Invested Capital (ROIC) | 17.93% |
| Return on Capital Employed (ROCE) | 30.67% |
| Revenue Per Employee | $1.39M |
| Profits Per Employee | $3,478 |
| Employee Count | 253 |
| Asset Turnover | 0.86 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, IRWD has paid $64.32 million in taxes.
| Income Tax | 64.32M |
| Effective Tax Rate | 98.65% |
Stock Price Statistics
The stock price has decreased by -90.79% in the last 52 weeks. The beta is 0.30, so IRWD's price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | -90.79% |
| 50-Day Moving Average | 1.49 |
| 200-Day Moving Average | 3.77 |
| Relative Strength Index (RSI) | 22.54 |
| Average Volume (20 Days) | 4,676,397 |
Short Selling Information
The latest short interest is 11.25 million, so 6.95% of the outstanding shares have been sold short.
| Short Interest | 11.25M |
| Short Previous Month | 16.25M |
| Short % of Shares Out | 6.95% |
| Short % of Float | 9.10% |
| Short Ratio (days to cover) | 3.87 |
Income Statement
In the last 12 months, IRWD had revenue of $351.41 million and earned $880,000 in profits. Earnings per share was $0.01.
| Revenue | 351.41M |
| Gross Profit | 343.86M |
| Operating Income | 95.72M |
| Pretax Income | 88.16M |
| Net Income | 880,000 |
| EBITDA | 97.73M |
| EBIT | 95.72M |
| Earnings Per Share (EPS) | $0.01 |
Full Income StatementBalance Sheet
The company has $88.56 million in cash and $599.48 million in debt, giving a net cash position of -$510.92 million or -$3.16 per share.
| Cash & Cash Equivalents | 88.56M |
| Total Debt | 599.48M |
| Net Cash | -510.92M |
| Net Cash Per Share | -$3.16 |
| Equity (Book Value) | -301.34M |
| Book Value Per Share | -1.88 |
| Working Capital | 143.52M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $103.55 million and capital expenditures -$142,000, giving a free cash flow of $103.41 million.
| Operating Cash Flow | 103.55M |
| Capital Expenditures | -142,000 |
| Free Cash Flow | 103.41M |
| FCF Per Share | $0.64 |
Full Cash Flow StatementMargins
Gross margin is 97.85%, with operating and profit margins of 27.24% and 0.25%.
| Gross Margin | 97.85% |
| Operating Margin | 27.24% |
| Pretax Margin | 18.55% |
| Profit Margin | 0.25% |
| EBITDA Margin | 27.81% |
| EBIT Margin | 27.24% |
| FCF Margin | 29.43% |
Dividends & Yields
IRWD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.99% |
| Shareholder Yield | -2.99% |
| Earnings Yield | 0.75% |
| FCF Yield | 87.94% |
Dividend DetailsAnalyst Forecast
The average price target for IRWD is $4.94, which is 579.51% higher than the current price. The consensus rating is "Buy".
| Price Target | $4.94 |
| Price Target Difference | 579.51% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | -0.59% |
| EPS Growth Forecast (5Y) | 162.04% |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IRWD has an Altman Z-Score of -3.35 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.35 |
| Piotroski F-Score | 6 |